$1995 | Single User
$2995 | Multi User
$5995 | Site License
$9995 | Global License

Global Animal Health Partnering Terms and Agreements 2010 to 2016
[Lowest Price Guaranteed: $1,995]

Published by Current Partnering: 01 Oct 2016 | 361 | In Stock
Related Topics: Technology

Introduction

Welcome to the Global Animal Health Partnering Terms and Agreements 2010 to 2016 report.


The report provides a detailed understanding and analysis of how and why companies enter Animal Health partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.


This report provides details of the latest Animal Health agreements announced in the life sciences since 2010.


The report takes the reader through a comprehensive review Animal Health deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Animal Health partnering deals.


The report presents financial deal term values for Animal Health deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.


The middle section of the report explores the leading dealmakers in the Animal Health partnering field; both the leading deal values and most active Animal Health dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.


One of the key highlights of the report is that over 400 online deal records of actual Animal Health deals, as disclosed by the deal parties, are included towards the end of the report in a directory format – by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.


In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.


The initial chapters of this report provide an orientation of Animal Health dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Animal Health dealmaking since 2010, including details of headline, upfront, milestone and royalty terms.


Chapter 3 provides a review of the leading Animal Health deals since 2010. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.


Chapter 4 provides a comprehensive listing of the top 25 most active companies in Animal Health dealmaking with a brief summary followed by a comprehensive listing of Animal Health deals announded by that company, as well as contract documents, where available.


Chapter 5 provides a comprehensive and detailed review of Animal Health partnering deals signed and announced since Jan 2010, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.


Chapter 6 provides a comprehensive and detailed review of Animal Health partnering deals signed and announced since Jan 2010. The chapter is organized by specific Animal Health technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.


A comprehensive series of appendices is provided organized by Animal Health partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.


The report also includes numerous tables and figures that illustrate the trends and activities in Animal Health partnering and dealmaking since 2010.


In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Animal Health technologies and products.


Key benefits


Global Animal Health Partnering 2010-2016: Deal trends, players, financials and forecasts provides the reader with the following key benefits:


In-depth understanding of Animal Health deal trends since 2010

Access to headline, upfront, milestone and royalty data

Analysis of the structure of Animal Health agreements with real life case studies

Detailed access to actual Animal Health contracts entered into by leading biopharma companies

Identify most active Animal Health dealmakers since 2010

Insight into terms included in a Animal Health partnering agreement, with real world examples

Understand the key deal terms companies have agreed in previous deals

Undertake due diligence to assess suitability of your proposed deal terms for partner companies


Report scope


Global Animal Health Partnering 2010-2016: Deal trends, players, financials and forecasts is intended to provide the reader with an in-depth understanding and access to Animal Health trends and structure of deals entered into by leading companies worldwide.


Animal Health Partnering Terms and Agreements includes:


Trends in Animal Health dealmaking in the biopharma industry since 2010

Analysis of Animal Health deal structure

Access to headline, upfront, milestone and royalty data

Case studies of real-life Animal Health deals

Access to Animal Health contract documents

Leading Animal Health deals by value since 2010

Most active Animal Health dealmakers since 2010


In Global Animal Health Partnering 2010-2016: Deal trends, players, financials and forecasts, the available deals are listed by:


Company A-Z

Headline value

Stage of development at signing

Deal component type

Specific therapy target

Technology type


Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


The Global Animal Health Partnering 2010-2016: Deal trends, players, financials and forecasts report provides comprehensive access to available deals and contract documents for over 400 Animal Health deals.


Analyzing actual contract agreements allows assessment of the following:


What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How aresalesand payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Table of Contents
for Global Animal Health Partnering Terms and Agreements 2010 to 2016

  • Executive Summary

    Chapter 1 – Introduction

    Chapter 2 – Trends in Animal Health dealmaking

    2.1. Introduction

    2.2. Animal Health partnering over the years

    2.3. Most active Animal Health dealmakers

    2.4. Animal Health partnering by deal type

    2.5. Animal Health partnering by therapy area

    2.6. Animal Health partnering by technology type

    2.7. Deal terms for Animal Health partnering

    2.7.1 Animal Health partnering headline values

    2.7.2 Animal Health deal upfront payments

    2.7.3 Animal Health deal milestone payments

    2.7.4 Animal Health royalty rates

    Chapter 3 – Leading Animal Health deals

    3.1. Introduction

    3.2. Top Animal Health deals by value

    Chapter 4 – Most active Animal Health dealmakers

    4.1. Introduction

    4.2. Most active Animal Health dealmakers

    4.3. Most active Animal Health partnering company profiles

    Chapter 5 – Animal Health contracts dealmaking directory

    5.1. Introduction

    5.2. Animal Health contracts dealmaking directory

    Chapter 6 – Animal Health dealmaking by technology type

    Chapter 7 – Partnering resource center

    7.1. Online partnering

    7.2. Partnering events

    7.3. Further reading on dealmaking

    Appendices

    Appendix 1 – Animal Health deals by company A-Z

    Appendix 2 – Animal Health deals by stage of development

    Appendix 3 – Animal Health deals by deal type

    Appendix 4 – Animal Health deals by therapy area

    Appendix 5 – Deal type definitions

    About Wildwood Ventures

    Current Partnering

    Current Agreements

    Recent report titles from Current Partnering

    Table of figures

    Figure 1: Animal Health partnering since 2010

    Figure 2: Active Animal Health dealmaking activity– 2010 to 2016

    Figure 3: Animal Health partnering by deal type since 2010

    Figure 4: Animal Health partnering by disease type since 2010

    Figure 5: Animal Health partnering by technology type since 2010

    Figure 6: Animal Health deals with a headline value

    Figure 7: Animal Health deals with an upfront value

    Figure 8: Animal Health deals with a milestone value

    Figure 9: Animal Health deals with a royalty rate value

    Figure 10: Top Animal Health deals by value since 2010

    Figure 11: Most active Animal Health dealmakers 2010 to 2016

    Figure 12: Online partnering resources

    Figure 13: Forthcoming partnering events

Additional Details

Publisher

Current Partnering

Publisher Information

Reference

361 | CP1015

Number of Pages

306

Report Format

PDF

Current Partnering Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Animal Biotechnology - Technologies, Markets and Companies
SummaryThis report describes and evaluates animal biotechnology and its application in veterinary me...
01 Oct 2016 by Jain PharmaBiotech USD $3,500 More Info
Phibro Animal Health Corporation (PAHC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryPhibro Animal Health Corporation (Phibro), a subsidiary of BFI Co., LLC, is a diversified ani...
24 Aug 2016 by Global Data USD $250 More Info
Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer), End user (Research Institute, Cell Bank) - Global Forecasts to 2021
The cell expansion market is expected to reach USD 18.76 billion by 2021 from USD 8.34 billion in 20...
09 Jun 2016 by MarketsandMarkets USD $5,650 More Info
Veterinary Reference Laboratory Market by Technology (Clinical Chemistry, Hematology, Immunodiagnostics, Molecular Diagnostics), Application (Pathology, Bacteriology, Virology, Parasitology), Animal (Dog, Cat, Cattle, Pig) - Global Forecast to 2021
The global veterinary reference laboratories market is estimated to grow at a CAGR of 9.8% from 2016...
07 Jun 2016 by MarketsandMarkets USD $5,650 More Info
Veterinary Services Global Market Briefing 2016 Including: Animal Hospitals And Veterinary Clinics And Veterinary Laboratory Testing Services. Historic and Forecast Growth Rate 2011 – 2019 Covering: Asia, Europe, Americas, Middle East & Africa, Oceania
Veterinary Services Global Market Briefing provides strategists, marketers and senior management wit...
14 May 2016 by The Business Research Company USD $1,000 More Info
Phibro Animal Health Corporation (PAHC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryPhibro Animal Health Corporation (Phibro), a subsidiary of BFI Co., LLC, is a diversified ani...
04 May 2016 by Global Data USD $250 More Info
Elanco Animal Health, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryElanco Animal Health, Inc. (Elanco) a subsidiary of Eli Lilly and Company is a pharmaceutical...
27 Apr 2016 by Global Data USD $250 More Info
Elanco Animal Health, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryElanco Animal Health, Inc. (Elanco) a subsidiary of Eli Lilly and Company is a pharmaceutical...
10 Mar 2016 by Global Data USD $250 More Info
Phibro Animal Health Corporation (PAHC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryPhibro Animal Health Corporation (Phibro), a subsidiary of BFI Co., LLC, is a diversified ani...
09 Mar 2016 by Global Data USD $250 More Info
Cell Isolation/Cell Separation Market by Product (Reagent, Media, Serum, Bead, Centrifuge), Cell Type (Human, Stem Cell, Animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & End user (Hospital, Biotechnology) - Forecast to 2020
The global cell isolation market is expected to reach USD 6.3 billion by 2020 from USD 2.9 billion i...
11 Jan 2016 by MarketsandMarkets USD $4,650 More Info

This report is published by Current Partnering

Download Free Report Summary PDF

Global Animal Health Partnering Terms and Agreements 2010 to 2016 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...